Sagging Face Skin: New Genetically Engineered Anti-Aging Cream Restores Youthful Elasticity

Sagging Face Skin: New Genetically Engineered Anti-Aging Cream Restores Youthful Elasticity



SHARE THIS ARTICLE

New York, NY–(HISPANIC PR WIRE)–January 9, 2007–Effective against wrinkles and sagging skin, DermaLastyl-B, is the first anti-aging face cream to address the body’s inability to replenish the quality of declining skin. Older consumers, through continued regular application, may eventually replenish their elastin while helping protect against new wrinkles. Tests have shown that when DermaLastyl-B is applied daily, it can assist in protecting against elastin loss that comes through the normal aging process. Small amounts applied daily in early adulthood can maintain a youthful level of elastin.

A genetically engineered human elastin precursor, DermaLastyl-B helps restore elastic properties to the skin. Used properly, it will reduce the need for Botox or cosmetic surgery and extend the life of previous procedures.

“The primary active ingredient in DermaLastyl-B is a complex chain of over 600 amino acids. Such complex molecules are normally too large to work in a topical cosmetic application. Even the most advanced cosmetics sold today, such as Olay Regenerist and Strivectin contain much smaller peptide combinations of 6 amino acids at most. Independent studies of our patented delivery system noted significant uptake of synthetic human elastin into the outer skin layers. DermaLastyl-B helps reduce the onset and appearance of wrinkles and our customers order and re-order DermaLastyl-B, because they notice visible improvement reviving their wrinkled, aged, sagging skin with a new youthful elasticity,” reports Dr. Burt Ensley, Chairman and CEO of DermaPlus Products. Inc., the producer of DermaLastyl-B.

This new face cream product is based on patents and technology originally developed by Dr. Ensley to synthesize human skin allowing for scar less healing of battlefield injuries. He holds 17 patents in molecular biology including many covering cosmetic applications. Former Laboratory Head at Amgen, Dr. Ensley served on the National Science Foundation’s BIO-AC, is currently on the Board of the University of Arizona’s Bio 5 Institute, and an Adjunct Professor at Northern Arizona University.

Available only at http://www.Dermalastyl.com

Sagging Face Skin: New Genetically Engineered Anti-Aging Cream Restores Youthful Elasticity